Cannula Market by Application 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cannula Market
Cannula Market: Application (Cardiovascular, Oxygen Therapy, General Surgery, Cosmetic/Plastic, Orthopedic, Diabetes Treatment, Neurology) Product (Cardiac, Vascular, Others) Material (Plastic, Metal, Silicon) End-User (Hospitals, ASC, Other)-Forecast (2016-2021)
Report Code : HCR 0166
Published: 01 March, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Cannula is a flexible tube with a retractable and sharp inner core which is inserted into a vein or an artery or in other body cavities of a patient in order to remove or delivery of fluids for treatment or medical investigational procedures like infusing medication or obtaining blood samples. Significant factors for that are driving the demand of medical cannulas are decrease in procedure duration with their use and faster patient recovery times. The cannulas market is expected to witness profitable growth during the forecast period as there are increasing government and corporate funding in R&D, increasing number of patients undergoing surgical procedures, development in healthcare facilities, rising number of surgeries in the geriatric population, increasing demand for minimally invasive surgery (MIS) procedures, and increasing prevalence of lifestyle induced diseases such as obesity, introduction of new technology development by market partners such as single-use cannulas for surgical use, introduction of PROTEK Duo cannula, and new injection molding technology developed for the production of plastic medical needles.

This report identifies the global Cannula Market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Cannula Market.

Cannula Market

Geographically North America dominated cannula market, and Asia Pacific is projected to have the fastest growth, owing to increasing purchasing power of the middle class population, and rise in awareness about MIS techniques in countries such as China, India, and Japan,

This report segments cannula market on the basis of technology, by types of lights, by premises and regional market as follows:
  • Cannula Market, by Product: Cardiac, Vascular, Arthroscopy, Dermatology and Nasal
  • Cannula Market, by Application: Cardiovascular, Oxygen Therapy, General Surgery, Cosmetic/Plastic, Orthopaedic, Diabetes treatment, Neurology
  • The report has focused study on Cannula Market by material: metal, silicon and plastic
  • Cannula market, by End-User: Hospital, ASC and Other End Users (Blood Banks and Home Healthcare Facilities

This report has been further segmented into major regions, which includes detailed analysis of each region such as:
  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Rest of the World (RoW)

This report identifies all the major companies operating in the Cannula market. Some of the major companies’ profiles in detail are as follows:
  • Medtronic PLC.
  • Edward Lifescience Corporation
  • Terumo Corporation
  • Sorin Group
  • Smith & Nephew PLC.
1. Cannula Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Cannula Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing Corporate and Government Funding in Research and Development Field   
      4.1.2. Increasing Number of Patients Undergoing Various Surgical Procedures
      4.1.3. Improvement in Health Facilities
      4.1.4. Increase in Awareness About Neurodegenerative Disorders
   4.2. Restraints
      4.2.1. Highly Uncertain Regulatory Framework in the Medical Device Industry
      4.2.2. Inadequate Cannula Stabilization That Can Injure Nerve
   4.3. Opportunities
      4.3.1. Emerging Markets
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Cannula Market, By Product
   5.1. introduction
   5.2. Cardiac
   5.3. Vascular
   5.4. Arthroscopy
   5.5. Dermatology
   5.6. Nasal   
6. Cannula Market, By Application
   6.1. Introduction
   6.2. Cardiovascular
   6.3. Oxygen Therapy
   6.4. General Surgery
   6.5. Cosmetic/Plastic
   6.6. Orthopedic
   6.7. Diabetes Treatment
   6.8. Neurology
7. Cannula Market, By Material
   7.1. Introduction
   7.2. Plastic
   7.3. Metal
   7.4. Silicon
8. Cannula Market, By End-User
   8.1. Introduction
   8.2. Hospitals
   8.3. Ambulatory Surgical Centers (ASC)
   8.4. Other End Users (Blood Banks and Home Healthcare Facilities)
9. Cannula Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Cannula – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles
   11.1. Medtronic PLC.
      11.1.1. Introduction
      11.1.2. Financials
      11.1.3. Key Insights
      11.1.4. Key Strategy
      11.1.5. Product Portfolio
      11.1.6. SWOT Analysis
   11.2. Edward Lifescience Corporation
      11.2.1. Introduction
      11.2.2. Financials
      11.2.3. Key Insights
      11.2.4. Key Strategy
      11.2.5. Product Portfolio
      11.2.6. SWOT Analysis
   11.3. Terumo Corporation
      11.3.1. Introduction
      11.3.2. Financials
      11.3.3. Key Insights
      11.3.4. Key Strategy
      11.3.5. Product Portfolio
      11.3.6. SWOT Analysis
   11.4. Sorin Group
      11.4.1. Introduction
      11.4.2. Financials
      11.4.3. Key Insights
      11.4.4. Key Strategy
      11.4.5. Product Portfolio
      11.4.6. SWOT Analysis
   11.5. Smith & Nephew PLC.
      11.5.1. Introduction
      11.5.2. Financials
      11.5.3. Key Insights
      11.5.4. Key Strategy
      11.5.5. Product Portfolio
      11.5.6. SWOT Analysis
   11.6. Conmed Corporation
      11.6.1. Introduction
      11.6.2. Financials
      11.6.3. Key Insights
      11.6.4. Key Strategy
      11.6.5. Product Portfolio
      11.6.6. SWOT Analysis
   11.7. Smiths Medical
      11.7.1. Introduction
      11.7.2. Financials
      11.7.3. Key Insights
      11.7.4. Key Strategy   
      11.7.5. Product Portfolio
      11.7.6. SWOT Analysis
   11.8. Teleflex Incorporated
      11.8.1. Introduction
      11.8.2. Financials
      11.8.3. Key Insights
      11.8.4. Key Strategy
      11.8.5. Product Portfolio
      11.8.6. SWOT Analysis
   11.9. Maquet Holding B.V. & Co. KG.
      11.9.1. Introduction
      11.9.2. Financials
      11.9.3. Key Insights
      11.9.4. Key Strategy
      11.9.5. Product Portfolio
      11.9.6. SWOT Analysis
   11.10. Boston Scientific Corporation.
      11.10.1. Introduction
      11.10.2. Financials
      11.10.3. Key Insights
      11.10.4. Key Strategy
      11.10.5. Product Portfolio
      11.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll